Skip to content

DuraGen® ID2205Recalls & reported problems

Integra Lifesciences Corporation · DuraGen® Dural Graft Matrix 2in x 2in, 5cm x 5cm · Class 2 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10381780023586), received between Nov 3, 2023 and Nov 3, 2023 — classified as 1 injury.

1 other recall cover devices cleared under the same FDA submission (K982180); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 1 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Cerebrospinal Fluid Leakage1
  • Meningitis1
  • Sepsis1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 3, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THIS REPORT IS 2 OF 2 REPORTS LINKED TO MFG REPORT NUMBER 3003418325-2023-00014: A LEGAL CLAIM HAS BEEN MADE AGAINST DUREPAIR, FOR WHICH MEDTRONIC HAS REPORTING RESPONSIBILITY. CLAIM DETAILS READ AS FOLLOWS: "HIS PRODUCT WAS A CONFIRMED RECALLED LOT#. HE EXPERIENCED SEVERE COMPLICATIONS, INCLUDING FEVERS (107) SEPSIS AND POSSIBLE MENINGITIS. HE REPORTED THAT HE WAS EXTREMELY ILL, IN CRITICAL CONDITION, AND ALMOST DIED." OPERATIVE NOTES ASSOCIATED WITH THE CLAIM MADE AGAINST DUREPAIR MAKE MENTION OF DURAGEN AND DURASEAL WHICH WERE CONCOMITANTLY USED, AND READ AS FOLLOWS: EXCERPT OF OPERATIVE NOTES OF (B)(6) 2023: PREOPERATIVE DIAGNOSIS: CEREBRAL SPINAL FLUID LEAK, HYPOTHERMIA. POSTOPERATIVE DIAGNOSIS: CEREBRAL SPINAL FLUID LEAK, HYPOTHERMIA. PROCEDURE: REPAIR OF A CSF LEAK, EVACUATION OF PSEUDOMENINGOCELE, REPLACEMENT OF DURAL PATCH WITH BOVINE PERICARDIUM. ¿¿ONCE AGAIN, A SIGNIFICANT AMOUNT OF FLUID WAS NOTED IN THE TISSUES THROUGHOUT THE SURGICAL WOUND. A LARGE SAMPLE OF FLUID WAS THEN SENT TO THE MICROBIOLOGY LAB FOR SAMPLING. MAYO SCISSORS WERE USED TO CUT THE PREVIOUSLY PLACED SUTURES. A CEREBELLAR RETRACTOR WAS THEN PLACED IN THE SURGICAL WOUND TO GET GOOD EXPOSURE. THE PREVIO

    Patient problems: Cerebrospinal Fluid Leakage; Meningitis; Sepsis

    MAUDE report 18065561 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K982180. One submission often covers many models, so check the product and lot details in each record.

  • Z-1282-2013 · Mar 28, 2013 · Terminated
    Dural Graft Matrix DuraGen Dural Graft Matrix is an absorbable implant for repair of dural defects. DuraGen matrix is an easy to handle, soft, white, pliable, nonfriable, porous

Other DURA SUBSTITUTE devices

All DURA SUBSTITUTE devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page